U. Chetty et al., Management of the axilla in operable breast cancer treated by breast conservation: a randomized clinical trial, BR J SURG, 87(2), 2000, pp. 163-169
Background: In the treatment of operable breast cancer by breast conservati
on, the extent of axillary dissection, the need for radiotherapy to the axi
lla and the morbidity associated with these procedures have not been assess
ed adequately.
Methods: Patients with operable breast cancer were randomized to have level
III axillary node clearance (232 patients) or axillary node sample (234 pa
tients). Radiotherapy to the axilla was given selectively. Radiotherapy was
not given to those who had an axillary clearance. In the early part of the
study all patients who had node sample were treated by radiotherapy (54 pa
tients); subsequently this was modified to include only those who were node
positive. The morbidity to the shoulder and arm was assessed before and af
ter operation by measuring upper limb volume and circumference, and combine
d glenohumeral and scapular movement and muscle power.
Results: Comparing the two surgical policies, no difference was found in lo
cal (axillary clearance 14 versus sample 15), axillary (eight versus seven)
or distant (29 versus 29) recurrence. There was no statistically significa
nt difference in 5-year survival rate (clearance 82.1 versus sample 88.6 pe
r cent). Morbidity was least in those who had a node sample and no radiothe
rapy to the axilla. Radiotherapy to the axilla in patients who had a node s
ample resulted in a significant reduction in range of movement of the shoul
der, e.g. mean(s.e.) 2.2(0.6) cm reduction in lateral rotation at 3 years.
Surgical axillary clearance was associated with significant lymphoedema of
the upper limb, e.g. 4.1(0.7) per cent increase in arm volume at 3 years.
Conclusion: A selective policy for the management of the axilla is associat
ed with no increase in axillary recurrence or mortality rate compared with
routine axillary node clearance. Patients who are node negative after axill
ary sample can avoid radiotherapy or axillary clearance.